← Back to patent-cliff list
CAS 122852-75-9
5-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one
Codes: ALOS-003
Application context (from source-drug indications)
Irritable bowel syndromeAlosetron Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Alosetron Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-methyl-3,4-dihydrocyclopenta[b]indol-1(2H)-one→(E)-4-methyl-3,4-dihydrocyclopenta[b]indol-1(2H)-one oxime→5-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one→5-(chloromethyl)-4-methyl-1-trityl-1H-imidazole
5-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one→(4-methyl-1H-imidazol-5-yl)methanol→tert-butyl 5-(hydroxymethyl)-4-methyl-1H-imidazole-1-carboxylate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.